No association between the -1031 polymorphism in the TNF-α promoter region and type 1 diabetes

Human Immunology

Volumn 64, Issue 6, 2003, Pages 633-638

  Shbaklo, Hadia ^a   Azar, Sami T ^b   Terwedow, Henry ^c   Halaby, Georges ^d   Naja, Roy P ^a   Zalloua, Pierre A ^a,c  

^a Chronic Care Center Hazmieh   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Tumor necrosis factor alpha, polymorphism, HLA; Type 1 diabetes

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HLA TYPING; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LEBANON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD;

EID: 0037782096     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00053-3     Document Type: Article

References (37)

1. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411, 1992.
2. Beutler B: TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 43:227, 1995.
3. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J: Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol 139:4077, 1987.
4. Corbett JA, McDaniel ML: Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181:559, 1995.
5. Reimers JI, Andersen HU, Mauricio D, Pociot F, Karlsen AE, Petersen JS, Mandrup-Poulsen T, Nerup J: Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis. Diabetes 45:771, 1996.
6. Rabinovitch A, Suarez-Pinzon WL: Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139, 1998.
7. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A 87:968, 1990.
8. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87:1233, 1990.
9. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136, 1993.
10. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN: Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125, 1994.
11. Mueller C, Held W, Imboden MA, Carnaud C: Accelerated beta-cell destruction in adoptively transferred autoimmune diabetes correlates with an increased expression of the genes coding for TNF-alpha and granzyme A in the intra-islet infiltrates. Diabetes 44:112, 1995.
12. Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, Ohkuni M, Tatsuzawa O, Yokota S, Joo K, Ueda K, Sasazuki T, Kimura A, Itoh K, Kato H: Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5′-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 42:2577, 1999.
13. Seki N, Yamaguchi K, Yamada A, Kamizono S, Sugita S, Taguchi C, Matsuoka M, Matsumoto H, Nishizaka S, Itoh K, Mochizuki M: Polymorphism of the 5′-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type 1 (HTLV-I) uveitis. J Infect Dis 180:880, 1999.
14. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K: Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 1:351, 2000.
15. Yamagata K, Hanafusa T, Nakajima H, Sada M, Amemiya H, Noguchi T, Tanaka T, Kono N, Tarui S: HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 34:133, 1991.
16. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y: Genetic analysis of HLA class 11 alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35:419, 1992.
17. Thorsby E, Ronningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371, 1993.
18. Pociot F, Wilson AG, Nerup J, Duff GW: No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23:3050, 1993.
19. Moghaddam PH, Zwinderman AH, de Knijff P, Roep BO, Schipper RF, Van der Auwera B, Naipal A, Gorus F, Schuit F, Giphart MJ: TNFa microsatellite polymorphism modulates the risk of IDDM in Caucasians with the high-risk genotype HLA DQA1*0501-DQB1*0201/DQA1*0301-DQB1*0302. Belgian Diabetes Registry. Diabetes 46:1514, 1997.
20. Zimmerman PA, Guderian RH, Nutman TB: A new TNFA promoter allele identified in South American Blacks. Immunogenetics 44:485, 1996.
21. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605, 1998.
22. Kaijzel EL, van Krugten MV, Brinkman BM, Huizinga TW, van der Straaten T, Hazes JM, Ziegler-Heitbrock HW, Nedospasov SA, Breedveld FC, Verweij CL: Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 4:724, 1998.
23. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS: Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833, 1995.
24. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE: Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52:359, 1998.
25. Hamaguchi K, Kimura A, Seki N, Higuchi T, Yasunaga S, Takahashi M, Sasazuki T, Kusuda Y, Okeda T, Itoh K, Sakata T: Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55:10, 2000.
26. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539, 1998.
27. Dorman J: Molecular epidemiology of insulin-dependent diabetes mellitus: WHO DiaMond Project. WHO DiaMond Molecular Epidemiology Sub-Project Group. Gac Med Mex 133(Suppl 1):151, 1997.
28. Olerup O, Aldener A, Fogdell A: HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41: 119, 1993.
29. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355, 1995.
30. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A: A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:1443, 1999.
31. Laird NM, Horvath S, Xu X: Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36, 2000.
32. Horvath S, Xu X, Laird NM: The family based association test method: strategies for studying general genotypephenotype associations. Eur J Hum Genet 9:301, 2001.
33. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506, 1993.
34. Kamizono S, Yamada K, Seki N, Higuchi T, Kimura A, Nonaka K, Itoh K: Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens 55:449, 2000.
35. Zalloua PA, Terwedow H, Shbaklo H, Halaby G, Xu X, Azar ST: Host and Environmental Factors Defining the Epidemiology of Type 1 Diabetes in a Group of Lebanese Children and Young Adults. J Pediatr Endocrinol Metab in press, 2003.
36. Hancu N, Netea MG, Baciu I: High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom J Physiol 35:325, 1998.
37. Bopegamage SA, Petrovicova A: Tumour necrosis factor alfa and glucose levels in sera of mice infected with coxsackie B4 and A7 viruses. Acta Virol 42:409, 1998.